Mohamed Bastawisy

• Identifying the key decision driver for the processes of Pricing, Reimbursement and HTA in all EU27, Switzerland, and UK. • Structuring the content of a digital clinical outcome assessment "COA" library. • Responsible for the International Reference Pricing "IRP" Rule collection. • Identify trends related to data collection regulations during early access programs. • Identify healthcare policies, regulations, and reimbursement frameworks related to early access programs.

• Structured the Publication Index library. • Managed the collation and analysis of competitive intelligence. • Led weekly cross-functional meetings with various departments, including Medical Affairs, Regulatory Affairs, and Market Access, to promote alignment and collaboration, ensuring on-time product launches and effective life-cycle management. • Contributed to the planning and execution of Launch Readiness activities across Europe.

• Responsible for the company's pipeline in all accounts in Dubai. • Negotiated annual contracts with hospitals' purchasers. • Ensured the availability, reimbursement, access, and liquidation of the company's products. • Conducted customer segmentation in line with the company's guidelines. • Maximized sales by 30% and increased market share by 10% of the company's products in accounts

• Maximized sales against target 2019 YTD 125%. • Developed and maintained relationships with key stakeholders in the relevant industry to gather insights

• Responsible for the Diabetes portfolio products (Onglyza and Kombiglyze). • Analyzed sales data to improve results and make sure resources are effectively allocated. • Achieved business growth (2017 YTD 15%) and (2018 YTD 25%) within agreed budget and time scales.

• Responsible for implementing the company's marketing plan of respiratory line. • Maximized sales against target for three years respectively (2016 YTD135%, 2015 YTD123%, 2014 YTD118%).